IDRX
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. IDRx is headquartered in Plymouth, Massachusetts and was founded in 2022.
IDRX
Industry:
Biotechnology Life Science Product Research
Founded:
2022-01-01
Address:
Plymouth, Massachusetts, United States
Country:
United States
Website Url:
http://www.idrx.com
Total Employee:
11+
Status:
Active
Total Funding:
122 M USD
Current Advisors List
Advisor
Advisor
Current Employees Featured
Ben Auspitz Co-Founder and CEO @ Idrx
Co-Founder and CEO
Alexis Borisy Co-Founder @ Idrx
Co-Founder
Shrenik Desai Vice President, Regulatory Affairs @ Idrx
Vice President, Regulatory Affairs
Jessica Christo Chief Development Operations Officer @ Idrx
Chief Development Operations Officer
Vic Kadambi Chief Product Development Officer @ Idrx
Chief Product Development Officer
Robert Forrester Co-Founder @ Idrx
Co-Founder
Nicholas Lydon Co-Founder @ Idrx
Co-Founder
George Demetri Co-Founder @ Idrx
Co-Founder
Debbie Johnson Vice President, Clinical Operations @ Idrx
Vice President, Clinical Operations
Founder
Investors List
Casdin Capital
Casdin Capital investment in Series A - Idrx
Forge Life Science Partners
Forge Life Science Partners investment in Series A - Idrx
Nextech Invest
Nextech Invest investment in Series A - Idrx
Andreessen Horowitz
Andreessen Horowitz investment in Series A - Idrx
Official Site Inspections
http://www.idrx.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Idrx"
Our Team – IDRx
At IDRx, we are committed to transforming the lives of patients with cancers that have well-characterized biology and significant unmet medical need – starting with GIST. Our Team Our …See details»
IDRx To Be Acquired by GSK For $1 Billion Upfront, And Additional …
4 days ago The Public M&A and Life Sciences teams advised IDRx, Inc. on its agreement to be acquired by GSK plc (LSE/NYSE: GSK) for $1 billion upfront, with potential for an additional …See details»
GSK enters agreement to acquire IDRx, Inc.
4 days ago IDRX-42 was generally well-tolerated and treatment-related adverse events (TRAEs) were mainly low grade at the recommended phase Ib dose. 4. Tim Clackson, CEO, IDRx, said: …See details»
Contact – IDRx
IDRx is a virtual-first company – email and electronic communication is the best way to reach us. Specific contacts and our mailing address are as follows: General Contact. info@idrx.com. …See details»
GlaxoSmithKline acquires Idrx - 2025-01-13 - Crunchbase
4 days ago Idrx Idrx is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment. Acquiring Organization: GlaxoSmithKline GlaxoSmithKline develops and …See details»
GSK to buy US biotech firm IDRx for up to $1.15 billion
3 days ago British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a rare type of …See details»
Idrx - Crunchbase Company Profile & Funding
Organization. Idrx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with …See details»
GSK buys US-based rare cancer treatment developer for up to £1bn
3 days ago GSK will pay one billion US dollars (£820 million) upfront to acquire the equity interests of IDRx, with the potential for an extra 150 million dollars (£124 million) paid …See details»
GSK Nears $1 Billion Deal for Biotech Company IDRx - BNN …
Jan 8, 2025 (Bloomberg) -- GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its …See details»
IDRx Company Profile 2025: Valuation, Funding
IDRx General Information Description. Developer of oncology-based precision therapies intended to revolutionize the treatment of cancer. The company designs precision combination therapies, medicines with highly selective, engineered …See details»
IDRx - Leadership Team - The Org
The Leadership Team at IDRx is responsible for strategic decision-making and guiding the company's vision in developing precision combination therapies for cancer care. This team, …See details»
GSK nears $1bn deal for biotech developing drug for rare tumour
Jan 8, 2025 IDRx is conducting early-stage trials of its targeted therapy for patients with a type of cancer called gastrointestinal stromal tumour, or Gist, which affects between 4,000 and …See details»
GSK to Buy US Biotech Firm IDRx for up to $1.15 Billion - U.S. News
4 days ago (Reuters) -British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a …See details»
IDRx Company Profile - Office Locations, Competitors, Revenue
IDRx is a clinical-stage biopharmaceutical company focused on drug development. It designs precision combination therapies for cancer treatment including small molecule tyrosine kinase …See details»
IDRx - The Org
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies.IDRx is headquartered in Plymouth, …See details»
IDRx Company Profile | Management and Employees List - Datanyze
IDRx headquarters are located in 52a Court St, Plymouth, Massachusetts, 02360, United States What are IDRx’s primary industries? IDRx’s main industries are: Business Services, Research …See details»
IDRx Strengthens Executive Team with Appointments of Tim …
Mar 12, 2024 IDRx’s lead program is IDRX-42, designed to inhibit key genetic drivers and drug-resistant mutations of KIT in gastrointestinal stromal tumor (GIST). IDRx’s pipeline also …See details»
Idrx - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Idrx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... and Advisor Profiles 3. Contacts 4. About. Idrx has 11 current …See details»
IDRX, Inc. Company Profile | Plymouth, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for IDRX, Inc. of Plymouth, MA. Get the latest business insights from Dun & Bradstreet.See details»
GSK confirms plan to buy cancer firm IDRx for $1bn
3 days ago GSK said that IDRX-42 addresses all the key KIT mutations that drive tumour growth and progression in GIST, which is estimated to affect between 4,000 and 6,000 people in the …See details»